BRKR: BRUKER CORP Profile

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets open in 14 hrs, 48 mins

Symbol	Value	Change	Percentage Change
DJIA	11,288.54	73.03	0.65%
NASDAQ	2,245.38	-6.08	-0.27%
S&P 500	1,262.90	1.38	0.11%

BRUKER CORP

BRKR

Stock price

12.74 -0.07 -0.55%

as of 01:00 PM EDT on 07/03/2008 in USD (NASDAQ Delay: 15 mins.)
Extended Hours

— — —

Analyst Consensus

Buy
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts

Insightful information about industries, companies, and the people who lead them.

Learn More.

2007 Sales	2007 Sales Growth	2007 Net Income	2007 Employees
$547,600,000	25.6%	$31,500,000	2,212

Key Executives: BRKR

Name	Title	Officer Since
Frank H. Laukien, Ph.D.	CEO	2/26/08
William J. Knight, C.P.A.	CFO	-
Dirk D. Laukien, Ph.D.	Senior VP	2/26/08
Dr. Tony W. Keller, Ph.D.	Director	2/26/08
Dr. Wolf-Dieter Emmerich, Ph.D	Director	2/26/08
Brenda J. Furlong	Director	2/26/08
Richard A. Packer	Director	2/26/08
Brian P. Monahan, C.P.A.	Controller/Executive VP, Subsidiary	-

View All Key Executives

Dr. Dirk Laukien is a Senior Vice President of the Company and has served in this capacity since July 1, 2006. Dr. Dirk Laukien also serves as the President of Bruker Optics and had served in this capacity for more than five years prior to July 1, 2006, the date we acquired our Bruker Optics subsidiary. Dirk Laukien also serves as co-CEO of the Bruker BioSpin Group and, since 1989, has served as co-President and director of Bruker BioSpin... View Full Profile

Dirk D. Laukien, Ph.D.

Dr. Keller currently serves as Executive Chairman of the Bruker BioSpin Group, chairman of the board of Bruker BioSpin AG, and as a director of Bruker BioSpin Inc. In addition, in 2008 prior to the completion of the Bruker BioSpin Group acquisition, Dr. Keller was elected to serve as President of the Board of BioSpin Invest AG. Until recently, Dr. Keller was co-CEO of the Bruker BioSpin Group and served in that capacity for more than five years.... View Full Profile

Dr. Tony W. Keller, Ph.D.

Dr. Emmerich currently serves as a consultant to Erich Netzsch Holding, the parent company of Netzsch Instruments, a developer and manufacturer of high-precision instruments for Thermal Analysis and thermophysical properties measurement headquartered in Selb, Germany. Netzsch's products are employed in research and quality control in a range of industrial applications. Dr. Emmerich joined Netzsch Instruments Ltd. in 1970 and served the Netzsch... View Full Profile

Dr. Wolf-Dieter Emmerich, Ph.D

From July 2003 to August 2006, Ms. Furlong served as Managing Director and Head of Fixed Income of Columbia Management Group, the primary investment management division of Bank of America Corporation. Prior to joining Columbia Management, Ms. Furlong was with The Hartford Financial Services Group, where she served as Chief Investment Officer and was President of Hartford Investment Management Company from October 1999 to November 2001, and also... View Full Profile

Brenda J. Furlong

Since November 1999, Mr. Packer has been the Chairman and Chief Executive Officer of ZOLL Medical Corporation (ZOLL), a publicly-traded manufacturer of resuscitation devices and related software solutions. From 1996 until his appointment to Chairman and Chief Executive Officer in 1999, Mr. Packer served as ZOLL's President, Chief Operating Officer and Director. From 1992 to1996, he served as ZOLL's Chief Financial Officer and Vice President of... View Full Profile

Richard A. Packer

Mr. Monahan has been the Corporate Controller of the Company since April 2004. From July 2004 through January 2005, Mr. Monahan served as the Assistant Vice President of Finance for Bruker Daltonics. In January 2005 Mr. Monahan was named the Vice President of Finance for Bruker Daltonics, and in November 2006, he was named Executive Vice President of Bruker Daltonics. Before joining the Company, Mr. Monahan served as the Manager of Accounting and... View Full Profile

Brian P. Monahan, C.P.A.

Dr. Fesik is currently the Divisional Vice President of Cancer Research of Abbott Laboratories, a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics headquartered in Illinois. Dr. Fesik joined Abbott Laboratories in 1983 and since that time served in various research and scientific capacities until being... View Full Profile

Dr. Stephen W. Fesik, Ph.D.

Dr. Laukien has been the Chairman, President and Chief Executive Officer of the Company since the inception of its predecessor company in February 1991. He also served as Executive Chairman of the former Bruker AXS from August 2002 until the merger of Bruker Daltonics and Bruker AXS in July 2003. In addition, from October 1997 to August 2002, he served as the Chairman of the board of directors and, from October 1997 to March 2000, as the Chief... View Full Profile

Frank H. Laukien, Ph.D.

Mr. Knight joined Bruker BioSciences as the Chief Financial Officer and Treasurer in October 2004. Before joining Bruker BioSciences, Mr. Knight served as Chief Financial Officer of Anika Therapeutics, Inc., a provider of therapeutic products, from 2002 to 2004. He also served as Chief Financial officer of Zycos, Inc., a developer of DNA-based therapeutic products, from 2000 to 2002, and as Chief Financial Officer of NMT Medical, Inc., a provider... View Full Profile

William J. Knight, C.P.A.

Mr. Knight joined Bruker BioSciences as the Chief Financial Officer and Treasurer in October 2004. Before joining Bruker BioSciences, Mr. Knight served as Chief Financial Officer of Anika Therapeutics, Inc., a provider of therapeutic products, from 2002 to 2004. He also served as Chief Financial officer of Zycos, Inc., a developer of DNA-based therapeutic products, from 2000 to 2002, and as Chief Financial Officer of NMT Medical, Inc., a provider... View Full Profile

Daniel S. Dross

Mr. Kniss joined the Company's board of directors in July 2003 in connection with the merger of Bruker Daltonics and Bruker AXS and joined the former Bruker AXS board of directors in June 2001. Mr. Kniss was Senior Vice President and General Manager for Agilent Technologies, Chemical Analysis Group, a producer of gas and liquid chromatographs, mass spectrometers and spectrophotometers, from August 1999 until March 2001. Prior to the spin-off of... View Full Profile

Richard D. Kniss

Mr. Joerg Laukien is the Chief Operating Officer of the European Bruker BioSpin companies. Joerg Laukien has been a director and President of Bruker BioSpin MRI, Inc. in Billerica, Massachusetts since 1997, President of Bruker BioSpin MRI GmbH in Ettlingen, Germany since 1998, President of Bruker Elektronik GmbH in Rheinstetten, Germany since 1991, a director of Bruker BioSpin Inc. in Billerica, Massachusetts since 2000, a director of Bruker... View Full Profile

Joerg C. Laukien

Mr. Wangler joined the Company's board of directors in February 2000. Mr. Wangler has been a German tax consultant and principal partner with Kanzlei Wangler in Karlsruhe, Germany since July 1983. He has been a Certified Public Accountant in Germany since 1984. Mr. Wangler holds a Bachelor of Economics and Commerce degree and a M.B.A. from the University of Mannheim, Germany.... View Full Profile

Bernhard Wangler

Mr. Stein joined Bruker BioSciences' board of directors in February 2000 and is the Company's secretary. Since January 1993, Mr. Stein has been a partner with Nixon Peabody LLP, a law firm, or a predecessor entity, Hutchins, Wheeler & Dittmar. Mr. Stein holds a B.A. degree from Brandeis University and a J.D. from Boston College Law School.... View Full Profile

Richard M. Stein, J.D.

Dr. Linton serves as the lead director of our board of directors. He was appointed lead director in March 2004 by the independent members of the board of directors. As lead director, Dr. Linton performs the usual responsibilities of a lead director including setting the agenda for board meetings and acting as a liaison between management and the board of directors. Dr. Linton has served as the Chairman and Chief Executive Officer of Promega... View Full Profile

William A. Linton

From 1997 to April 2006, Mr. D'Silva served as the Chief Executive Officer of Transgenomic, Inc., a life science company involved in SNP discovery, in Omaha, Nebraska. Until January 2007, Mr. D'Silva also served as the Chairman of the board of directors of Transgenomic. From 1988 to 1997, Mr. D'Silva was President and Chief Executive Officer of CETAC Technologies, Inc, a company designing instrumentation for elemental analysis. Mr. D'Silva holds... View Full Profile

Collin J. D'Silva

Top Competitors: BRKR

View Detailed Competitors Chart

Insider Trends: BRKR
Sentiment for BRKR is POSITIVE
- 0M
- 2M
- 4M
- 6M
- Market Value of Insider Sales
- Market Value of Insider Purchases
Total dollar value of all insider purchases and sales over 12 months
View All Insider Sentiment

Insider Transactions: BRKR

Date	Name	Shares	Transaction Type	Market Value
06/13/08	LAUKIEN JOERG C	8,020	Exercise of Stock Options	$63,441.80
06/09/08	LAUKIEN FRANK H	50,000	Purchase	$579,755.10
05/15/08	LAUKIEN FRANK H	100,000	Exercise of Stock Options	$571,000.00

View All Insider Activity

Ownership Breakdown : BRKR

Large Block Holder Type	Number
Institutions	171.00
Mutual Fund	287.00
Other Major	16.00

Full Details

Indices : BRKR

Symbol	Name	Last Trade	Change
$RUT.X	Russell 2000 Index	—	——%

View all Indices that include BRKR

Short Interest Volume: BRKR

Data as of 6/10/08

Current Short Interest Shares	1.10 B
Current Short Interest Ratio	9.30
Float	50.54 M

Short Interest as % of Float	10.60
Average Daily Volume	654,000.00
Outstanding Shares	163.36 M

Full Details

SEC Filings: BRKR

Accepted Date	Description
06/16/2008	SEC Filing: Insider Buy/Sell
06/10/2008	SEC Filing: Insider Buy/Sell
05/19/2008	SEC Filing: Insider Buy/Sell

View all SEC Filings

Get Profile Details for:

- Help & Feedback

Market Movers

Related Resources

My Portfolios

AOL Real-Time Streaming Quotes

BRUKER CORP

BRKR

Stock price

12.74 -0.07 -0.55%

as of 01:00 PM EDT on 07/03/2008 in USD (NASDAQ Delay: 15 mins.)
Analyst Consensus
- Strong Buy
- Buy
- Hold
- Sell
- Strong Sell
- Add to Portfolio
- Add to Alerts

Quote Search Search the Web Search

More in Money & Finance
- Money
- Earnings
- Tech News
- Stock Screener
- Banking
- Checking Account
- Savings Account
- Credit Cards
- Credit Reports
- Identity Theft
- Debt Management
- Loans
- Auto Loan
- Personal Loans
- Mortgages
- Refinancing
- Taxes
- Online Tax Filing
- Tax Advice
- Tax Basics
- Tax Forms
- Audit
- Tax Credit
- Tax Deduction
- AMT
- Small Business
- BloggingStocks
- BloggingBuyouts
- Luxist
- TUAW
- DJIA
- Dow Jones Industrial Average
More Stock Research
Notices and Terms: Confirm all data with your broker before trading.

Quote data provided by Interactive Data. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Financial.

The BRUKER CORP profile at AOL Money & Finance provides you with all the brkr investing information you need. Reference AOL Money & Finance before you make your next investment!

© 2008 AOL LLC. All Rights Reserved.

AOL@Money © 2008 AOL LLC. All Rights Reserved.

Live Updates:

Ticker

Dynamic view of the market

BRUKER CORP

BRKR

Stock price

Extended Hours

Analyst Consensus

BRUKER CORP Profile

Key Executives: BRKR

Top Competitors: BRKR

Insider Trends: BRKR

Insider Transactions: BRKR

Ownership Breakdown : BRKR

Indices : BRKR

Short Interest Volume: BRKR

SEC Filings: BRKR

Quote Details

Classic Chart

Advanced Chart BETA

Real-Time Headlines

Message Boards

Profile

Earnings Analysis

Event Calendar

Financials